Cargando…
Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822595/ http://dx.doi.org/10.1016/j.ajog.2022.11.597 |
| _version_ | 1784865982314971136 |
|---|---|
| author | El Sharaiha, Rand Chen, Katherine Russell, Kirsten Azeem, Nabila Bergman, Celeste Zarudskaya, Oxana Khurshid, Nauman |
| author_facet | El Sharaiha, Rand Chen, Katherine Russell, Kirsten Azeem, Nabila Bergman, Celeste Zarudskaya, Oxana Khurshid, Nauman |
| author_sort | El Sharaiha, Rand |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9822595 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98225952023-01-09 Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy El Sharaiha, Rand Chen, Katherine Russell, Kirsten Azeem, Nabila Bergman, Celeste Zarudskaya, Oxana Khurshid, Nauman Am J Obstet Gynecol Poster Session II Published by Mosby, Inc. 2023-01 2023-01-07 /pmc/articles/PMC9822595/ http://dx.doi.org/10.1016/j.ajog.2022.11.597 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session II El Sharaiha, Rand Chen, Katherine Russell, Kirsten Azeem, Nabila Bergman, Celeste Zarudskaya, Oxana Khurshid, Nauman Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title | Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title_full | Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title_fullStr | Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title_full_unstemmed | Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title_short | Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy |
| title_sort | identifying antepartum patients at risk for developing allergic reactions from covid-19 monoclonal antibody therapy |
| topic | Poster Session II |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822595/ http://dx.doi.org/10.1016/j.ajog.2022.11.597 |
| work_keys_str_mv | AT elsharaiharand identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT chenkatherine identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT russellkirsten identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT azeemnabila identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT bergmanceleste identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT zarudskayaoxana identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy AT khurshidnauman identifyingantepartumpatientsatriskfordevelopingallergicreactionsfromcovid19monoclonalantibodytherapy |